The American Association of Gynecologic Laparoscopists (AAGL) has joined several other ob/gyn organizations to endorse the US Surgeon General's recommendation to suspend elective surgeries amidst the coronavirus (COVID-19) pandemic.
The American Association of Gynecologic Laparoscopists (AAGL) has joined several other ob/gyn organizations to endorse the US Surgeon General's recommendation to suspend elective surgeries amidst the coronavirus (COVID-19) pandemic. Other organizations supporting this recommendation include the American College of Obstetricians and Gynecologists (ACOG), the American Society of Reproductive Medicine (ASRM), the American Urogynecologic Society (AUGS), Society of Family Planning (SFP), Society of Gynecologic Oncology (SGO), Society of Gynecologic Surgeons (SGS) and Society for Maternal-Fetal Medicine (SMFM).
As the impact of the pandemic continues to intensify, the resources of the health care system, hospital systems, clinics, and communities will be further strained. The Surgeon General’s statement urging healthcare providers to suspend elective surgeries is part of a broader strategy to free up resources. AAGL notes that surgical procedures performed by ob/gyns are generally medically indicated procedures necessary for patient health and safety. However, in areas where COVID-19 is particularly prevalent or where there is already stress on the health care system, modifying surgical scheduling could help preserve resources.
The organization reiterates that the recommended suspension is for elective procedures only. Obstetric and gynecologic procedures for which a delay could negatively impact the patient’s health or pregnancy should not be delayed. However, it is also important to be cognizant of the unintended effects that COVID-19 cases and policies may have on a healthcare provider’s time, including limiting access to time-sensitive obstetric and gynecological procedures.
At this unusual time and with circumstances rapidly evolving, it is important for ob/gyns to stay updated on the most-up-to-date policies. AAGL recommends consulting the CDC’s Interim Guidance for Healthcare Facilities: Preparing for Community Transmission of COVID-19 in the United States.
Advancing obstetric and gynecologic surgery through robotic innovation
April 30th 2024Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Understanding VTE and bleeding risks in gynecologic noncancer surgery
April 15th 2024Delve into the nuanced risks of venous thromboembolism and major bleeding post-gynecologic noncancer surgery, exploring procedure-specific variations and the implications for thromboprophylaxis strategies.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More